Log in
Enquire now
Tern Therapeutics

Tern Therapeutics

Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases.

OverviewStructured DataIssuesContributors

Contents

terntx.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Therapeutics
Therapeutics
Research and development
Research and development
Pharmaceutical industry
Pharmaceutical industry
Location
Washington, D.C.
Washington, D.C.
B2X
B2B
B2B
CEO
‌
Alex M. Bailey
Number of Employees (Ranges)
1 – 10
Email Address
patientadvocacy@terntx.com
medinfo@terntx.com
info@terntx.com
Investors
‌
Steve Oliveira
ATW Partners
ATW Partners
Total Funding Amount (USD)
15,000,000
Latest Funding Round Date
August 27, 2024
CFO
‌
Matthew Rosini
Latest Funding Type
Seed
Seed

Other attributes

Latest Funding Round Amount (USD)
15,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Tern Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.